Quick Answer
CytoMed Therapeutics Ltd reported Total Assets of $6.21 million for fiscal year 2025.
CytoMed Therapeutics Ltd — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $6.21M -38.3% |
$10.07M -18.6% |
$12.37M +136.6% |
$5.23M -14.1% |
$6.08M | — |
| R&D Expense | $2.22M +16.1% |
$1.91M +20.1% |
$1.59M +4.4% |
$1.52M +39.6% |
$1.09M +5.1% |
$1.04M |
- CytoMed Therapeutics Ltd reported Total Assets of $6.21 million for fiscal year 2025.
- CytoMed Therapeutics Ltd showed a decrease of -38.3% in Total Assets compared to the prior fiscal year.
- CytoMed Therapeutics Ltd reported R&D Expense of $2.22 million for fiscal year 2025.
- CytoMed Therapeutics Ltd showed an increase of +16.1% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: